Citius Pharmaceuticals, Inc.
CTXR · NASDAQ
9/30/2024 | 9/30/2023 | 9/30/2022 | 9/30/2021 | |
|---|---|---|---|---|
| Market Cap | $145,113 | $166,680 | $294,600 | $367,427 |
| - Cash | $3,252 | $26,481 | $41,712 | $70,073 |
| + Debt | $263 | $481 | $678 | $855 |
| Enterprise Value | $142,124 | $140,680 | $253,566 | $298,209 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$210 | -$194 | -$180 | -$165 |
| % Margin | – | – | – | – |
| EBITDA | -$38,640 | -$31,773 | -$32,885 | -$22,879 |
| % Margin | – | – | – | – |
| Net Income | -$39,139 | -$32,543 | -$33,641 | -$23,125 |
| % Margin | – | – | – | – |
| EPS Diluted | -5.97 | -5.57 | -5.76 | -5.64 |
| % Growth | -7.2% | 3.3% | -2.1% | – |
| Operating Cash Flow | -$28,201 | -$29,060 | -$28,361 | -$24,250 |
| Capital Expenditures | $0 | $0 | $0 | -$40,007 |
| Free Cash Flow | -$28,201 | -$29,060 | -$28,361 | -$64,257 |